Detlev Biniszkiewicz Ph.D

Detlev Biniszkiewicz Ph.D General Information

Biography

Dr. Detlev Biniszkiewicz serves as Managing Director, Investments at MPM Capital. Dr. Biniszkiewicz previously serves as Board Member at DEKA Biosciences. He serves as Chairman at NextPoint. He was a Board member of Tilos Therapeutics & Maverick Therapeutics. He serves as Board Member at Surface Oncology. He has over 15 years of industry leadership and experience building a transformative pipeline of novel cancer therapies most recently as the head of the oncology strategy at AstraZeneca. Prior to joining Surface, he held positions at AstraZeneca, Novartis, and the Boston Consulting Group. Most recently he was Vice President, Oncology Strategy at AZ where he led the aggressive and very successful strategy to rebuild the AZ oncology portfolio into a robust pipeline of novel therapies with strong emphasis on immuno-oncology. Prior to that, he was the Global Head of Portfolio Management at the Novartis Institute for Biomedical Research. Earlier in his career he was a principal in the pharmaceutical practice at the Boston Consulting Group and completed his scientific training at the Jaenisch Laboratory at Whitehead Institute in the Massachusetts Institute of Technology. He serves as Board Member at Montis Biosciences.